<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: It is still unclear whether <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> (IBD) patients with <z:mpath ids='MPATH_270'>adenomas</z:mpath> have a higher risk of developing high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (HGD) or <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) than non-IBD patients with <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:mpath ids='MPATH_270'>adenomas</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>We compared the risk of advanced <z:hpo ids='HP_0002664'>neoplasia</z:hpo> (AN, defined as HGD or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) in IBD patients with <z:mpath ids='MPATH_270'>adenomas</z:mpath> to IBD patients without <z:mpath ids='MPATH_270'>adenomas</z:mpath> and patients without IBD with <z:mpath ids='MPATH_270'>adenomas</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: IBD patients with a histological <z:mpath ids='MPATH_270'>adenoma</z:mpath> diagnosis (IBD + <z:mpath ids='MPATH_270'>adenoma</z:mpath>), age-matched IBD patients without <z:mpath ids='MPATH_270'>adenoma</z:mpath> (IBD-nonadenoma), and <z:mpath ids='MPATH_270'>adenoma</z:mpath> patients without IBD (nonIBD + <z:mpath ids='MPATH_270'>adenoma</z:mpath>) were enrolled in this study </plain></SENT>
<SENT sid="3" pm="."><plain>Medical charts were reviewed for <z:mpath ids='MPATH_270'>adenoma</z:mpath> characteristics and development of AN </plain></SENT>
<SENT sid="4" pm="."><plain>The endoscopic appearance of the <z:mpath ids='MPATH_270'>adenomas</z:mpath> was characterized as typical (solitary sessile or pedunculated) or atypical (<z:hpo ids='HP_0000001'>all</z:hpo> other descriptions) </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: A total of 110 IBD + <z:mpath ids='MPATH_270'>adenoma</z:mpath> patients, 123 IBD-nonadenoma patients, and 179 nonIBD + <z:mpath ids='MPATH_270'>adenoma</z:mpath> patients were included </plain></SENT>
<SENT sid="6" pm="."><plain>Mean duration of follow-up was 88 months (SD Â±41) </plain></SENT>
<SENT sid="7" pm="."><plain>The 5-year cumulative risks of AN were 11%, 3%, and 5% in IBD + <z:mpath ids='MPATH_270'>adenoma</z:mpath>, IBD-nonadenoma, and nonIBD + <z:mpath ids='MPATH_270'>adenoma</z:mpath> patients, respectively (P &lt; 0.01) </plain></SENT>
<SENT sid="8" pm="."><plain>In IBD patients atypical <z:mpath ids='MPATH_270'>adenomas</z:mpath> were associated with a higher 5-year cumulative risk of AN compared to IBD patients with typical <z:mpath ids='MPATH_270'>adenomas</z:mpath> (18% vs. 7%, P = 0.03) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: IBD patients with a histological diagnosis of <z:mpath ids='MPATH_270'>adenoma</z:mpath> have a higher risk of developing AN than <z:mpath ids='MPATH_270'>adenoma</z:mpath> patients without IBD and IBD patients without <z:mpath ids='MPATH_270'>adenomas</z:mpath> </plain></SENT>
<SENT sid="10" pm="."><plain>The presence of atypical <z:mpath ids='MPATH_270'>adenomas</z:mpath> in particular was associated with this increased risk, although patients with typical <z:mpath ids='MPATH_270'>adenomas</z:mpath> were found to carry an additional risk as well </plain></SENT>
</text></document>